Search
NovaBay Pharmaceuticals Inc
NBYAdd to Watchlist
1.950USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
68.61MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
-93.36%
Year to Date
-93.09%
1 Year
-6.20%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
67736.52%Turnover Ratio
1.950Prev. Close
0.000Low
0.00Turnover
LossP/E Static
-0.00P/B
0.00%Div Yield TTM
-533.34%ROA
99.75052wk High
2.01Volume Ratio
-8.61MNet Profit
941.29Shares
-3.8043EPS TTM
0.28Beta
1307.03%ROE
1.11052wk Low
25.79%Amplitude
8.06%Gross Margin
68.61MMarket Cap
1.10Reward/Risk
13.07%Risk Rate
TradingKey Stock Score of NovaBay Pharmaceuticals Inc
Currency: USD Updated: 2026-04-02Key Insights
NovaBay Pharmaceuticals Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 131 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 0.85.In the medium term, the stock price is expected to trend down.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
NovaBay Pharmaceuticals Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
NovaBay Pharmaceuticals Inc Highlights
StrengthsRisks
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Undervalued
The company’s latest PE is -0.51, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.42M shares, increasing 43.87% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 365.85K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.07.
Analyst Rating
Based on
0
analysts
--
Current Rating
0.850
Target Price
-18.27%
Upside Space
NovaBay Pharmaceuticals Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
NovaBay Pharmaceuticals Inc Info
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Ticker SymbolNBY
CompanyNovaBay Pharmaceuticals Inc
CEOKazley (Michael John)
Websitehttps://novabay.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of NovaBay Pharmaceuticals Inc (NBY)?
The current price of NovaBay Pharmaceuticals Inc (NBY) is 1.95.
What is the symbol of NovaBay Pharmaceuticals Inc?
The ticker symbol of NovaBay Pharmaceuticals Inc is NBY.
What is the 52-week high of NovaBay Pharmaceuticals Inc?
The 52-week high of NovaBay Pharmaceuticals Inc is 99.75.
What is the 52-week low of NovaBay Pharmaceuticals Inc?
The 52-week low of NovaBay Pharmaceuticals Inc is 1.11.
What is the market capitalization of NovaBay Pharmaceuticals Inc?
The market capitalization of NovaBay Pharmaceuticals Inc is 68.61M.
What is the Earnings Per Share (EPS TTM) of NovaBay Pharmaceuticals Inc (NBY)?
The Earnings Per Share (EPS TTM) of NovaBay Pharmaceuticals Inc (NBY) is -3.80.